PTEN and cancer: As shown in Fig. 6, we concluded that these 4 CPGs were significantly associated with the risk of corresponding most mutated cancer types, especially PTEN (HR = 0.74, P = 2.2e-06) and SMAD4 (HR = 0.75, P = 9e-04).